Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigation of the Safety and Efficacy of Once Weekly NNC0519-0130 in Participants With Overweight or Obesity - a Dose Finding Study

NCT06326060 is registered in ClinicalTrials.gov with Novo Nordisk A/S as lead sponsor.

NCT NCT06326060
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06326060 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigation of the Safety and Efficacy of Once Weekly NNC0519-0130 in Participants With Overweight or Obesity - a Dose Finding Study
Lead sponsor
Novo Nordisk A/S
Phase
Phase 2
Overall status
Completed
Start date
March 18, 2024
Completion date
May 1, 2025
Enrollment
354 (actual)
Sites
70

Conditions

As the registry lists them; a condition with its own page is linked.

obesity